Home › Funds › Propel Bio Management, LLC › COLL
Propel Bio Management, LLC position in COLL
COLLEGIUM PHARMACEUTICAL INC · Health Care
Propel Bio Management, LLC reported holding 410,175 shares of COLL (COLLEGIUM PHARMACEUTICAL INC) in its Q3 2026 13F filing — a position valued at US$9.0M, representing 4.75% of its reported portfolio and ranking #4 among its reported holdings. Propel Bio Management, LLC first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Propel Bio Management, LLC's COLL position evolved
Propel Bio Management, LLC first disclosed a stake in COLL in Q3 2026 at 410,175 shares (US$9.0M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 410.18K | $8.95M | New |
About COLL and 13F data
COLL (COLLEGIUM PHARMACEUTICAL INC) is a Health Care company. 29 other funds we track also report a position in COLL — the largest reported positions include TENOR CAPITAL MANAGEMENT Co., L.P. (US$85.8M), EVENTIDE ASSET MANAGEMENT, LLC (US$49.3M), GOLDENTREE ASSET MANAGEMENT LP (US$26.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding COLL
- TENOR CAPITAL MANAGEMENT Co., L.P. 68.81M sh · $85.79M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 1.36M sh · $49.27M · Q2 2026
- GOLDENTREE ASSET MANAGEMENT LP 744.89K sh · $26.92M · Q2 2026
- SILVERBACK ASSET MANAGEMENT LLC 15.30M sh · $18.79M · Q2 2026
More on Propel Bio Management, LLC
FAQ
How long has Propel Bio Management, LLC held COLL?
Propel Bio Management, LLC has disclosed COLL holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Propel Bio Management, LLC's current position in COLL?
As of Q3 2026, Propel Bio Management, LLC holds 410.18K shares of COLL (COLLEGIUM PHARMACEUTICAL INC), valued at $8.95M, representing 4.75% of its reported portfolio and ranking #4.
Has Propel Bio Management, LLC been buying or selling COLL?
In the latest 13F filing (Q3 2026), Propel Bio Management, LLC newly opened its position in COLL.
Which other funds hold COLL?
Other major institutional holders of COLL include TENOR CAPITAL MANAGEMENT Co., L.P., EVENTIDE ASSET MANAGEMENT, LLC, GOLDENTREE ASSET MANAGEMENT LP, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.